Biotech

All Articles

Basilea scores $268M BARDA funding for antifungals, anti-biotics

.Basilea Pharmaceutica's job establishing new antifungals has gotten a considerable increase coming ...

Capricor markets Europe civil rights to late-stage DMD treatment for $35M

.Having already scooped up the U.S. civil liberties to Capricor Rehabs' late-stage Duchenne muscular...

FDA junks adcomm for Applied's rare ailment drug

.After pushing back the choice meeting for Applied Therapeutics' metabolic disorder drug govorestat,...

Novo inks $600M NanoVation package to examine genetic drugs ex-liver

.Novo Nordisk is continuing its press into genetic medications, agreeing to compensate NanoVation Th...

Innovent web links cytokine to colorectal cancer responses

.Innovent Biologics has produced the situation that its own gate inhibitor-cytokine fusion healthy p...

Merck, Daiichi ADC attacks target in period 3 bronchi cancer research

.A phase 3 trial of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (...

Rakovina grows AI focus with collab to select cancer aim ats

.5 months after Rakovina Therapies turned toward artificial intelligence, the cancer-focused biotech...

Ascendis' dwarfism drug smash hits in period 3, threatens BioMarin

.Ascendis Pharma has emerged as a prospective risk to BioMarin's Voxzogo, stating stage 3 growth pro...

Despite ph. 3 overlook, Alkeus views pathway ahead of time for eye disease possession

.Though Alkeus Pharmaceuticals' dental eye illness possession fell short to substantially reduce geo...

Kairos goes public with $6M IPO to cash tests of cancer cells drug

.Along with a trio of biotechs striking the Nasdaq on Friday, it was actually quick and easy to miss...